艾德尔米德罗 (Adelmidrol) 用于对抗儿童上呼吸道炎症:一项试点病例对照研究,以确定安全性和有效性
Antonio Della Volpe1, Chiara Bruno1, Pietro De Luca2
1Otolaryngology Department, Santobono-Posillipon Hospital, Via Mario Fiore 6, 80129, Naples, Italy.
概括
阿德尔米德洛喷雾有效治疗儿童上呼吸道炎症 (URT). 与标准治疗相比,结合鼻腔和口腔Adelmidrol喷雾剂显示出优异的结果,提供了一个潜在的更安全的替代方案.
科学领域:
- 儿科耳鼻喉科 儿科耳鼻喉科
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 上呼吸道 (URT) 炎症在儿童中很常见,通常用粘结剂和类固醇治疗.
- 对于儿科URT炎症的类固醇治疗有风险,例如改变气味,需要更安全的替代品.
- 由于其安全性概况,阿德尔米德被探索为儿科URT炎症的潜在治疗剂.
研究的目的:
- 评估Adelmidrol在治疗儿童上呼吸道炎症 (URT) 的疗效.
- 为了比较Adelmidrol的有效性与标准的粘结剂和类固醇治疗.
- 评估Adelmidrol在儿科患者中的安全性和不良反应概况.
主要方法:
- 一项涉及60名患有URT炎症的2.5至4.5岁儿童的病例控制研究.
- 参与者被随机分配到对照组 (标准治疗) 和两个Adelmidrol治疗组 (仅使用鼻喷雾或鼻和口腔喷雾).
- 对URT和耳膜的评估是在基线,30天和90天进行的,连续治疗90天.
主要成果:
- 接受鼻腔和口腔Adelmidrol喷雾的组在URT发现 (p=0.0004) 和 tympanic膜条件 (p=0.03) 中表现得明显更好.
- 单独使用阿德尔米德罗尔鼻雾剂的疗效与标准治疗组相比相当.
- 在阿德尔米德罗尔治疗组中没有报告任何不良反应.
结论:
- 阿德尔米德罗 (Adelmidrol) 的疗效与标准治疗相比,当作为小儿URT炎症的鼻喷雾剂使用时,其疗效相当于标准治疗.
- 鼻腔和口腔Adelmidrol喷雾剂的组合似乎比标准治疗更有效.
- 阿德尔米德罗 (Adelmidrol) 对儿科URT炎症的传统疗法提供了一个有希望的替代方案,可能会提供类似的益处,但没有副作用.
更多相关视频
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
244
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
244
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
158
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
158
01:20Asthma: Pathogenesis and Management
231
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
231
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
133
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
133
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
156
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
156
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K